Pancreatic Cancer Research

ResearcherCedars-Sinai Medical CenterNo recent work listed

Wenwen Chien

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5109601696. Sources: OpenAlex.

Their work

Papers
5
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2013: 1 paper · 2014: 2 papers · 2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper

Papers 5

  1. Functional Genome-wide Screening Identifies Targets and Pathways Sensitizing Pancreatic Cancer Cells to Dasatinib. Co-author DOI 10.7150/jca.25138↗
  2. Activation of protein phosphatase 2A tumor suppressor as potential treatment of pancreatic cancer. Co-author DOI 10.1016/j.molonc.2015.01.002↗
  3. Growth inhibition of pancreatic cancer cells by histone deacetylase inhibitor belinostat through suppression of multiple pathways including HIF, NFkB, and mTOR… Co-author DOI 10.1002/mc.22024↗
  4. Selective inhibition of unfolded protein response induces apoptosis in pancreatic cancer cells. Co-author DOI 10.18632/oncotarget.2051↗
  5. PIAS4 is an activator of hypoxia signalling via VHL suppression during growth of pancreatic cancer cells. Co-author DOI 10.1038/bjc.2013.531↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Harold Phillip Koeffler · 5 shared papers, 2013–2018 · strength 0.22
  2. Yun Zheng · 2 shared papers, 2014–2018 · strength 0.10
  3. Manoj Garg · 2 shared papers, 2014–2018 · strength 0.10
  4. Hiroyuki Kato · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.